Most Read Articles
Tristan Manalac, 16 Aug 2019
Patients with nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) suffer from higher surgical morbidity and posthepatectomy liver failure, according to a new Singapore study.
Roshini Claire Anthony, 07 May 2019

The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress (ILC 2019).

Gearing up for the 12th Liver Updates

Pank Jit Sin
28 Jun 2017

Liver Update is a series of international scientific meetings organized by the Malaysian Liver Foundation. It is meant to keep our healthcare professionals (HCPs) updated on current developments and new advances in the management of liver diseases. Usually held around mid to late July, the conference is a must-go for hepatologists, GPs and allied health professionals alike.

MIMS Doctor got in touch with Tan Sri Dato’ Seri Dr. Haji Mohd Ismail Merican, founder and president of the Malaysian Liver Foundation, to get his views about the upcoming event. He said: “It is imperative that our HCPs keep themselves updated on current advances in the approach and management of common liver disorders found in this country so that their patients will be given the right information and advice.”

Mohd Ismail said patients are nowadays actively searching for information on the World Wide Web and it is therefore imperative that HCPs know more about liver diseases than their patients. Also, information on the internet may be misleading, which requires a well-informed and up-to-date HCP to put the patient back on track. “This is in fact part of continuing professional development and is an important factor in the practice of medicine, as information is ever evolving, even as we speak, and none of our HCPs should be left behind clinging to outdated knowledge.”

This year’s Liver Update has been organized with great effort to bring world renowned experts to share their experiences and knowledge with our HCPs. Recent developments pertaining to liver diseases have ignited both hope and concern amongst healthcare professionals and policy makers. Mohd Ismail said: “Now we have a realistic possibility of a cure for patients with chronic hepatitis C, a major public health problem globally.” However, on the other end of the spectrum, the increasing incidence of non-alcoholic fatty liver disease (NAFLD) which is associated with obesity, diabetes mellitus, hyperlipidaemia, the metabolic syndrome and lifestyle diseases is a great concern to all of us.

The event will see lectures from local and overseas ‘superstars’ in hepatology. Overseas speakers include the following: 

·         Professor Dr. Edward Gane from New Zealand

·         Professor Dr. Henry Chan  from Hong Kong

·         Dr. Thomas Leung from Hong Kong

·         Professor  Dr. Mohamad Rela  from India

·         Dr. Richard Guan from Singapore

·         Dr. Rohit Agarwal from Singapore

·         Dr. Chow Wan Cheng from Singapore

·         Professor Dr.Laurentius Lesmana from Indonesia

·         Professor Dr.Teerha Piratvisuth from Thailand

 

Meanwhile the local speakers list comprises:


·         Datuk Dr. Ryan Ponnudurai

·         Mr. Krishnan Raman

·         Datin Dr. Sharmila Sachithanandan

·         Dr. Manisekhar Subramaniam

·         Datuk Dr. Shahnaz Murad

·         Dr. L. Sanker

·         Dato' Dr. Christopher Lee

·         Professor Dato' Dr. Nor Shahidah Khairullah

·         Prof Dato Dr. Ravindran Jegasothy

·         Dato Dr. Robert Ding

·         Dato ‘ Dr. Nik Ritza Kosai Nik Mahmud

·         Dr. Tan Soek Siam

·         Dr. Haniza Omar

·         Dato Dr.  Mazlam Mohd Zawawi

·         Datuk (Mr) Harjit Singh

 

When asked which particular sessions he deem as ‘must-attend’ sessions, Mohd Ismail said all sessions are important, it just depends on the interest of the delegate. “If I can make a suggestion, sessions on chronic hepatitis C and fatty liver should be attractive to participants in view of recent developments.”

The conference will be looking at a more than 300 participants with more slated to register on the spot.  Specialists, doctors and allied healthcare professionals including pharmacists, assistant medical officers and nurses should make their way to the event.


Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 16 Aug 2019
Patients with nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) suffer from higher surgical morbidity and posthepatectomy liver failure, according to a new Singapore study.
Roshini Claire Anthony, 07 May 2019

The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress (ILC 2019).